BOLD
Boundless Bio
BOLD
BOLD
44 hedge funds and large institutions have $9.88M invested in Boundless Bio in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
98% less capital invested
Capital invested by funds: $419M → $9.88M (-$409M)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$216K | |
| 2 | +$202K | |
| 3 | +$108K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$107K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$55.8K |
Top Sellers
| 1 | -$399M | |
| 2 | -$3.29M | |
| 3 | -$570K | |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$378K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$363K |
